This feature rounds up venture capital news and highlights larger deal coverage already published.
* A $33 million series B funding for Glycomine Inc., a biotechnology company developing new treatments for rare diseases, was led by Novo Holdings A/S. Other round participants include new investors Asahi Kasei Pharma Corp. and Mission Bay Capital, as well as existing backers Sanderling and Chiesi Ventures. Glycomine collected $12.0 million in a series A round in November 2016.
* Ezoic Inc., an artificial intelligence-based platform for digital publishers, obtained $33 million in growth capital from Sageview Capital. Ezoic pulled in $5.6 million in a series A round in November 2013.
* Mobile-first personal sales assistant Vymo raised $18 million in a series B financing round led by Emergence Capital, with participation from current investor Sequoia India. Vymo obtained about $5.0 million in a series A round in November 2016.
Additional coverage
Sweden-based Klarna Bank's valuation hits $5.5B after latest funding round
American Family Ventures raises $162.5M for VC fund
Unless otherwise noted, historical funding data is sourced from the S&P Global Market Intelligence platform.
